Clinical features of Parkinsonian patients with the α-synuclein (G209A) mutation

Movement Disorders

Volumn 16, Issue 6, 2001, Pages 1007-1013

  Bostantjopoulou, S ^a   Katsarou, Z ^a   Papadimitriou, A ^b   Veletza, V ^b   Hatzigeorgiou, G ^b   Lees, A ^c  

^a Aristoteleion Panepistimeion Thessalonikis   (Greece)

^b Neurology Department   (Greece)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Familial parkinsonism; G209A mutation; synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC DISORDER; GEOGRAPHIC DISTRIBUTION; GREECE; HUMAN; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NEUROPSYCHOLOGY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; SYMPTOMATOLOGY; TREMOR;

EID: 0035526288     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1221     Document Type: Review

References (49)

1. Golbe LI, Di Iorio G, Bonavita V, et al. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990;27: 276-282.
2. Markopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 1995;38:373-378.
3. Golbe LI, Di Iorio G, Sanges G, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996;40: 767-775.
4. Wood N. Genes and parkinsonism. J Neurol Neurosurg Psychiatry 1997;62:305-309.
5. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
6. Munoz E, Oliva R, Obach V. et al. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients. Neurosci Lett 1997;235:57-60.
7. Warner TT, Schapira AHV. The role of the α-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom. J Neurol Neurosurg Psychiatry 1998;65:378-379.
8. Vaughan J, Durr A, Tassin J, et al. The α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease. Ann Neurol 1998;44:270-273.
9. Bennett P, Nicholl DJ. Absence of the G209A mutation in the alpha-synuclein gene in British families with Parkinson's disease. Neurology 1998;50:1183.
10. Wang WW, Khajavi M, Patel BJ, et al. The G209A mutation in the α-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations. Arch Neurol 1998;55:1521-1523.
11. Farrer M, Wavrant-De Vrieze F, Crook R, et al. Low frequency of α-synuclein mutations in familial Parkinson's disease. Ann Neurol 1998;43:394-397.
12. Chan P, Tanner CM, Jiang X, Langston JW. Failure to find the α-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998;50:513-514.
13. Chan P, Jiang X, Forno LS, et al. Absence of mutations in the coding region of α-synuclein gene in pathologically proven Parkinson's disease. Neurology 1998;50:1136-1137.
14. Lin JJ, Yueh KC, Chang DC, Lin SZ. Absence of G209A and G88C mutations in the alpha-synuclein gene of Parkinson's disease in a Chinese population. Eur Neurol 1999;42:217-220.
15. Hu CJ, Sung SM, Liu H, Chang JG. No mutation of G209A in the alpha-synuclein gene in sporadic Parkinson's disease among Taiwan Chinese. Eur Neurol 1999;41:85-87.
16. Chan DKY, Mellick G, Cai H, et al. The α-synuclein gene and Parkinson disease in a Chinese population. Arch Neurol 2000;57: 501-503.
17. Gwinn-Hardy KA, Crook R, Lincoln S, et al. A kindred with Parkinson's disease not showing genetic linkage to established loci. Neurology 2000;54:504-507.
18. Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998; 18:106-108.
19. Markopoulou K, Wszolek ZK, Pfeiffer RF, Chase BA. Reduced expression of the G209A α-synuclein allele in familial Parkinsonism. Ann Neurol 1999;46:374-381.
20. Athanassiadou A, Voutsinas G, Psiouri L, et al. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding α-synuclein. Am J Hum Genet 1999;65:555-558.
21. Papadimitriou A, Veletza V, Hadjigeorgiou GM, et al. Mutated α-synuclein gene in two Greek Kindred with familial PD: incomplete penetrance? Neurology 1999;52:651-654.
22. CAPIT Committee: Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
23. Fahn S, Elton R, Members of the UPDRS Development Committee. In: Fahn S, Marsden CP, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease, vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987. p 153-163, 293-304.
24. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson's disease. Neurology 1983;33:943-946.
25. Doty RL. The Smell Identification Test™ administration manual. Philadelphia: Sensonics; 1983.
26. Beck AT, Ward CH, Mendelson, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
27. Mattis S. Dementia Rating Scale professional manual. Odessa, FL: Psychological Assessment Resources; 1988.
28. Brown L. Sherbenou RJ, Johnsen SK. Test of nonverbal intelligence, 2nd ed. Austin, TX: Pro-ed; 1990.
29. Wechsler D. Wechsler Memory Scale - revised. San Antonio, TX: Psychological Corp., Harcourt Brace Jovanovich; 1987.
30. Heaton RK, Chelune GJ, Talley JL, et al. Wisconsin Card Sorting Test manual. Revised and expanded. Odessa FL: Psychological Assessment Resources; 1993.
31. Shalice T. Specific impairments of planning. Philos Trans R Soc Lond B 1982;298:199-209.
32. Lezak MD. Neuropsychological assessment, 2nd ed. New York: Oxford University Press; 1983.
33. Benton AL, Spreen O. Embedded Figures Test. Manual of Instructions and Norms. Univ Victoria: Neuropsychological Test Sales; 1969.
34. Wechsler D. WAIS - R, manual. San Antonio, TX: Psychological Corp., Harcourt Brace; 1981.
35. Poppelreuter W. Die psychischen Schadigungen dutch Kopfschuss in Kriege. Vol 2. Leipzig, West Germany: Voss; 1914.
36. Kaplan E, Goodglass M, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger; 1983.
37. Bostantjopoulou S, Logothetis J, Katsarou Z, Mentenopoulos G. Clinical observations in early and late onset Parkinon's disease. Funct Neurol 1991;6:145-149.
38. Hughes AJ, Daniel SE, Kilford L, Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
39. Schrag A, Ben-Shlomo Y, Brown R, et al. Young-onset Parkinson's disease revisited - clinical features, natural history and mortality. Mov Disord 1998;13:885-894.
40. Golbe LI. Young-onset Parkinson's disease: a clinical review. Neurology 1991;41:68-173.
41. Gibb WRG, Lees AJ. A comparison of clinical and pathologic features of young- and old-onset idiopathic Parkinson's disease. Neurology 1988; 38:1402-1406.
42. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50: 140-148.
43. Kostic V, Przedborski S, Flaster E, Sternic N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology 1991;41:202-205.
44. Fahn S. Medical treatment of Parkinson's disease. J Neurol 1998;245(Suppl 3):P15-P24.
45. Levin BE, Katzen HL. Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. Adv Neurol 1995; 65:85-95.
46. Mohr E, Mendis T, Grimes JD. Late cognitive changes in Parkinson's disease with an emphasis on dementia. Adv Neurol 1995; 65:97-113.
47. Katsarou Z, Bostanjopoulou S, Alevriadou A, et al. A longitudinal study of visuospatial discrimination in parkinsonian patients. Percept Mot Skills 1998;86:171-180.
48. Alevriadou A, Katsarou Z, Bostarujopoulou S, et al. Wisconsin Card Sorting Test variables in relation to motor symptoms in Parkinson's disease. Percept Mot Skills 1999;89:824-830.
49. McKeith IG, Galasko D, Kosaka K, et al., for the Consortium of Dementia with Lewy Bodies. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.